Beijing Wantai Biological Pharmacy Enterprise Balance Sheet Health
Financial Health criteria checks 5/6
Beijing Wantai Biological Pharmacy Enterprise has a total shareholder equity of CN¥13.0B and total debt of CN¥320.2M, which brings its debt-to-equity ratio to 2.5%. Its total assets and total liabilities are CN¥15.6B and CN¥2.6B respectively. Beijing Wantai Biological Pharmacy Enterprise's EBIT is CN¥24.4M making its interest coverage ratio -0.1. It has cash and short-term investments of CN¥6.1B.
Key information
2.5%
Debt to equity ratio
CN¥320.17m
Debt
Interest coverage ratio | -0.1x |
Cash | CN¥6.13b |
Equity | CN¥13.00b |
Total liabilities | CN¥2.55b |
Total assets | CN¥15.56b |
Recent financial health updates
No updates
Recent updates
Some Investors May Be Willing To Look Past Beijing Wantai Biological Pharmacy Enterprise's (SHSE:603392) Soft Earnings
Apr 04Things Look Grim For Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHSE:603392) After Today's Downgrade
Apr 02Earnings Tell The Story For Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHSE:603392) As Its Stock Soars 27%
Feb 28Financial Position Analysis
Short Term Liabilities: 603392's short term assets (CN¥10.0B) exceed its short term liabilities (CN¥2.4B).
Long Term Liabilities: 603392's short term assets (CN¥10.0B) exceed its long term liabilities (CN¥173.9M).
Debt to Equity History and Analysis
Debt Level: 603392 has more cash than its total debt.
Reducing Debt: 603392's debt to equity ratio has increased from 1.5% to 2.5% over the past 5 years.
Debt Coverage: 603392's debt is well covered by operating cash flow (581.2%).
Interest Coverage: 603392 earns more interest than it pays, so coverage of interest payments is not a concern.